These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13570390)

  • 41. [Immunity status to tularemia in the population of Ivano-Frankovsk region].
    Vetchinin VV; Sukhopiatkina AA; Bat OS; Potapova VG
    Vrach Delo; 1979 Mar; (3):108-9. PubMed ID: 156464
    [No Abstract]   [Full Text] [Related]  

  • 42. Tularemia vaccine study. I. Intracutaneous challenge.
    SASLAW S; EIGELSBACH HT; WILSON HE; PRIOR JA; CARHART S
    Arch Intern Med; 1961 May; 107():689-701. PubMed ID: 13746668
    [No Abstract]   [Full Text] [Related]  

  • 43. Tularemia vaccine study. II. Respiratory challenge.
    SASLAW S; EIGELSBACH HT; PRIOR JA; WILSON HE; CARHART S
    Arch Intern Med; 1961 May; 107():702-14. PubMed ID: 13746667
    [No Abstract]   [Full Text] [Related]  

  • 44. [Improved preparation of dry living tularemia vaccine].
    KOLIADITSKAIA LS; SHMURYGINA AA
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Oct; 28(10):84-9. PubMed ID: 13531893
    [No Abstract]   [Full Text] [Related]  

  • 45. [Possibility of simultaneous vaccination against tularemia and brucellosis. I. Indices of immunologic transformation in guinea pigs following simultaneous subcutaneous and combined vaccination against tularemia and brucellosis].
    PILIPENKO VG; POLIAKOVA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Apr; 4():52-7. PubMed ID: 14387221
    [No Abstract]   [Full Text] [Related]  

  • 46. [Simultaneous vaccination by the epicutaneous method against plague, brucellosis and tularemia].
    UZBEKOVA BR; SHMUTER MF; ABDULLINA GA
    Zdravookhranenie Kazakhstana; 1962; 22(7)():63-8. PubMed ID: 13924058
    [No Abstract]   [Full Text] [Related]  

  • 47. [Agglutination reaction one year after recovery from tularemia].
    ROZOWSKI T; BIALUNSKA-KUDREWICZ S
    Przegl Epidemiol; 1955; 9(2):115-7. PubMed ID: 13254909
    [No Abstract]   [Full Text] [Related]  

  • 48. [The effect of pre-existing immunity against tularemia and brucellosis on the efficacy of vaccination with plague EB vaccine administered primarily in a combined plague, tularemia and brucellosis vaccine].
    Pilipenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Feb; 45(2):101-5. PubMed ID: 5650712
    [No Abstract]   [Full Text] [Related]  

  • 49. Agar gel precipitin analyses in laboratory-acquired tularemia.
    VOSTI KL; WARD MK; TIGERTT WD
    J Clin Invest; 1962 Jul; 41(7):1436-45. PubMed ID: 13926832
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experiences with tularin produced in Czechoslovakia. Dynamics of the development of intensity of a positive tularin test and determination of the most appropriate time to read it].
    Cerný Z
    Cas Lek Cesk; 1969 Jul; 108(28):838-50. PubMed ID: 5789558
    [No Abstract]   [Full Text] [Related]  

  • 51. [Tularemia beyond the Arctic Circle].
    Nekrasova LI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):17-9. PubMed ID: 4454838
    [No Abstract]   [Full Text] [Related]  

  • 52. [Serologic reactions in vaccinated and not vaccinated subjects against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Apr; 4():67-70. PubMed ID: 14387224
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the possibility of the use of the tularemia bacterium vaccine strain antigen (Tuallergen-2) for the rapid diagnosis of tularemia in humans].
    UGLOVOI GP; SAVEL'EVA RA; SHIPITSINA GK
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Dec; 33():102-7. PubMed ID: 13995224
    [No Abstract]   [Full Text] [Related]  

  • 54. [Properties of living dry vaccine against tularemia NIIEG and their relation to the duration of its preservation].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Sep; 27(9):20-2. PubMed ID: 13393672
    [No Abstract]   [Full Text] [Related]  

  • 55. [On the problem of the increase of immunogenic properties of live vaccine against tularemia].
    FAIBICH MM
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Oct; 30():20-4. PubMed ID: 13821310
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experiences with tularin made in Czechoslovakia. I. Analysis of results of intradermal tularin test in persons vaccinated with Soviet dry live anti-tularemic vaccine].
    Cerný Z
    Cas Lek Cesk; 1968; 107(45):1363-7. PubMed ID: 5685531
    [No Abstract]   [Full Text] [Related]  

  • 57. [Simultaneous vaccination of human subjects against brucellosis and tularemia. I].
    AMANZHULOV RS; REMENTSOVA MM
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Feb; 29(2):11-6. PubMed ID: 13570389
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experimental studies on a complex vaccine against plague and tularemia].
    KALACHEVA NF
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):78-83. PubMed ID: 13605101
    [No Abstract]   [Full Text] [Related]  

  • 59. [Determination of optimal concentration of tularine Sevac. Relationship between the tularine reaction intensity and concentration of Tularine following intradermal administration].
    Cerný Z
    Cas Lek Cesk; 1972; 111(17):381-7. PubMed ID: 5024668
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the study of revaccination in experimental and human tularemia].
    MATVEETS LS
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Feb; 31():14-22. PubMed ID: 13853861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.